Cargando…

Practical Application of DaTQUANT with Optimal Threshold for Diagnostic Accuracy of Dopamine Transporter SPECT

Evaluation of Parkinsonian Syndromes (PS) with Ioflupane iodine-123 dopamine transporter single photon emission computed tomography (DaT-SPECT), in conjunction with history and clinical examination, aids in diagnosis. FDA-approved, semi-quantitative software, DaTQUANT(TM) (GE Healthcare, Chicago, IL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neill, Matthew, Fisher, Julia M., Brand, Christine, Lei, Hong, Sherman, Scott J., Chou, Ying-Hui, Kuo, Phillip H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706562/ https://www.ncbi.nlm.nih.gov/pubmed/34941653 http://dx.doi.org/10.3390/tomography7040081

Ejemplares similares

Impact of age and sex correction on the diagnostic performance of dopamine transporter SPECT
por: Schmitz-Steinkrüger, Helen, et al.
Publicado: (2020)

Dopamine Transporter SPECT Imaging in Corticobasal Syndrome
por: Cilia, Roberto, et al.
Publicado: (2011)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders
por: AKDEMİR, Ümit Özgür, et al.
Publicado: (2021)

The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review
por: Suwijn, Sven R, et al.
Publicado: (2015)

Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study
por: Tsang, Kaki, et al.
Publicado: (2023)

Data-driven identification of diagnostically useful extrastriatal signal in dopamine transporter SPECT using explainable AI
por: Nazari, Mahmood, et al.
Publicado: (2021)

No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
por: Thomsen, Gerda, et al.
Publicado: (2013)

Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT
por: Pitkonen, Miia, et al.
Publicado: (2012)

Impact of the size of the normal database on the performance of the specific binding ratio in dopamine transporter SPECT
por: Schmitz-Steinkrüger, Helen, et al.
Publicado: (2020)

Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes
por: Vlaar, Annemarie MM, et al.
Publicado: (2007)

Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging
por: Covington, Matthew F., et al.
Publicado: (2015)

Using Artificial Neural Network to Discriminate Parkinson’s Disease from Other Parkinsonisms by Focusing on Putamen of Dopamine Transporter SPECT Images
por: Chien, Chung-Yao, et al.
Publicado: (2020)

Dopamine Transporter Imaging Using (99m)Tc-TRODAT-1 SPECT in Parkinson’s Disease
por: Bor-Seng-Shu, Edson, et al.
Publicado: (2014)

FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder
por: Meles, Sanne K., et al.
Publicado: (2017)

Bipolar Disorder and Parkinson's Disease: A (123)I-Ioflupane Dopamine Transporter SPECT Study
por: Erro, Roberto, et al.
Publicado: (2021)

Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
por: Thiele, Felix, et al.
Publicado: (2023)

Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes
por: Goto, Ryoji, et al.
Publicado: (2023)

Evaluation of dopamine transporter density in healthy Brazilians using Tc-99m TRODAT-1 SPECT
por: dos Reis, Marilia Alves, et al.
Publicado: (2021)

No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
por: Schiebler, Tassilo, et al.
Publicado: (2023)

Sex correction improves the accuracy of clinical dopamine transporter imaging
por: Honkanen, Emma A., et al.
Publicado: (2021)

The role of (123)I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies
por: Antonini, Angelo
Publicado: (2007)

Evaluation of Iterative Reconstruction Method and Attenuation Correction in Brain Dopamine Transporter SPECT Using an Anthropomorphic Striatal Phantom
por: Maebatake, Akira, et al.
Publicado: (2016)

Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools
por: Morbelli, Silvia, et al.
Publicado: (2020)

Multiple-pinhole collimators improve intra- and between-rater agreement and the certainty of the visual interpretation in dopamine transporter SPECT
por: Mathies, Franziska, et al.
Publicado: (2022)

Diagnostic accuracy of SPECT/CT arthrography in patients with suspected aseptic joint prostheses loosening
por: Bao, Bo, et al.
Publicado: (2021)

The Feasibility of Using CT-Guided ROI for Semiquantifying Striatal Dopamine Transporter Availability in a Hybrid SPECT/CT System
por: Hsu, Chien-Chin, et al.
Publicado: (2014)

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT
por: Mäkinen, Elina, et al.
Publicado: (2019)

Pilot Study for Correlation of Heart Rate Variability and Dopamine Transporter Brain Imaging in Patients with Parkinsonian Syndrome
por: Warhadpande, Devdutta S., et al.
Publicado: (2022)

Neuromelanin or DaT‐SPECT: which is the better marker for discriminating advanced Parkinson's disease?
por: Okuzumi, A., et al.
Publicado: (2019)

Wiener filter improves diagnostic accuracy of CAD SPECT images—comparison to angiography and CT angiography
por: Masoomi, Michael A., et al.
Publicado: (2019)

Differences of Various Region-of-Interest Methods for Measuring Dopamine Transporter Availability Using (99m) T c-TRODAT-1 SPECT
por: Yin, Tang-Kai, et al.
Publicado: (2014)

Dopamine Transporter maging with Tc-99m TRODAT-1 SPECT in Parkinson’s isease and its orrelation with linical isease everity
por: Patel, Asra, et al.
Publicado: (2019)

Faster Acquisition for Dopamine Transporter Imaging Using Swiftscan Step and Shoot Continuous SPECT Without Impairing Visual and Semiquantitative Analysis
por: Bailly, Matthieu, et al.
Publicado: (2020)

Experimental evaluation of absolute quantification in (99m)Tc‐TRODAT‐1 SPECT/CT brain dopamine transporter (DAT) studies
por: Zainudin, Norasma Amira, et al.
Publicado: (2022)

Deep learning regressor model based on nigrosome MRI in Parkinson syndrome effectively predicts striatal dopamine transporter-SPECT uptake
por: Bae, Yun Jung, et al.
Publicado: (2023)

Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease – An Unexpected Finding?
por: Bittner, Verena, et al.
Publicado: (2011)

Modelling multiple thresholds in meta-analysis of diagnostic test accuracy studies
por: Steinhauser, Susanne, et al.
Publicado: (2016)

Quality of reporting in cardiac MRI, CT and SPECT diagnostic accuracy studies: Analysis of the impact of STARD criteria
por: Maclean, Edd N, et al.
Publicado: (2013)

Voxel-based analysis of (201)Tl SPECT for grading and diagnostic accuracy of gliomas: comparison with ROI analysis
por: Kuwako, Tomoyuki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dtp7mgr9ipea1hj63u00f3h593